Federal Register of Legislation - Australian Government

Primary content

SR 1991 No. 442 Regulations as made
Principal Regulations; Repeals the (1991-1992 Pathology Services Table) Regulations.
Tabling HistoryDate
Tabled HR25-Feb-1992
Tabled Senate25-Feb-1992
Gazetted 19 Dec 1991
Date of repeal 01 Nov 1992
Repealed by Repealed by Health Insurance (1992-1993 Pathology Services Table) Regulations (SR 1992 No. 336).

Commonwealth Coat of Arms of Australia

Statutory Rules 1991 No.4421

–––––––

Health Insurance (1992 Pathology Services Table) Regulations2

I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Health Insurance Act 1973.

Dated 12 December 1991.

BILL HAYDEN

Governor-General

By His Excellency’s Command,

B.HOWE

Minister of State for Health, Housing and Community Services

–––––––––

Citation

1. These Regulations may be cited as the Health Insurance (1992 Pathology Services Table) Regulations.

Commencement

2. These Regulations commence on 1 February 1992.


 

Repeal

3. Statutory Rule 1991 No. 353 is repealed.

Pathology services table

4. The table of pathology services in the Schedule is prescribed for the purposes of subsection 4a (2) of the Health Insurance Act 1973.

SCHEDULE                                 Regulation 4

TABLE OF PATHOLOGY SERVICES

RULES OF INTERPRETATION

1. (1) In this table, unless the contrary intention appears:

“patient episode” means a pathology service, or pathology services whether listed in 1 or more items, for a single patient whose need for which was determined under subsection 16a (1) of the Act on the same day, whether rendered by 1 or more approved pathology practitioners on 1 or more days;

“recognised pathologist” means a medical practitioner recognised as a specialist in pathology under a determination under subsection 61 (3) of the Act;

“the Act” means the Health Insurance Act 1973.

 

(2) In these Rules, a reference to a request to an approved pathology practitioner includes a reference to a request for a pathologist-determinable service to which subsection 16a (6) of the Act applies.

 

2. (1) If a service is described:

(a) in an item in general terms; and

(b) in another item in specific terms;

only the item that describes the service in specific terms applies to the service.

 

(2) If:

(a) a service is described in 2 or more items; and

(b) subrule (1) does not apply;

only the item that provides the lower or lowest fee for the service applies to the service.


 

3. (1) In subrule (2), “service” includes an assay, estimation and test

(2) 2 or more pathology services rendered for a patient following 2 or more requests are taken to have been rendered following a single request if:

(a) the services are listed in the same item; and

(b) the patient’s need for die services was determined under subsection 16a (1) of the Act on the same day even if they are rendered by an approved pathology practitioner on more than one day.

4. If:

(a) a pathology service to which an item of the table applies is rendered for a patient in accordance with a request; and

(b) another pathology service is rendered for the patient in accord the request; and

(c) an item of the table:

(i) applies to the other service; and

(ii) is referred to in the item mentioned in paragraph (a);

the other service is treated as if it were part of the service referred to in paragraph (a).

Example:

Dr Proctor requests an extended blood grouping test (covered by item 65019) and the test includes a basic blood grouping test (covered by item 65017). Item 65017 is referred to in item 65019. Benefit is payable under item 65019 for the extended blood grouping test but benefit is not payable separately under item 65017 for the basic blood grouping test

5. For the purposes of items 65001 to 66200 (inclusive):

(a) if pathology services of a kind referred to in item 65017, 65018, 65019 or 65020 are rendered for a patient during a period when the patient is in hospital, the item applies only to the first pathology service of that kind rendered for the patient during that period; and

(b) tests (except the tests mentioned in items 65023 and 65024) carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

6. For the purposes of items 66201 to 69200 (inclusive):

(a) if a pathology service involving the measurement of a substance in urine requires a 24 hour urine collection, or calculation of a substance/ creatinine ratio, the service is treated as including any estimation of creatinine in other fluids necessary for the calculation; and


(b) tests earned out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

 

7. For the purposes of items 69201 to 71000 (inclusive):

(a) “serial examinations or cultures” means examinations or cultures requested on 1 occasion whether or not:

(i) the materials are received on different days by the approved pathology practitioner, or

(ii) the examinations or cultures were requested on 1 or more request forms by the treating practitioner; and

(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

 

8. For the purposes of items 71001 to 72800 (inclusive):

(a) in items 71025, 71026, 71027, 71028, 71029, 71030, 71031 and 71032, the estimation of a single antibody includes qualitative and quantitative assays for that antibody; and

(b) tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

9. For the purposes of items 72801 to 73040 (inclusive):

(a) “biopsy material” means all tissue received by the approved pathology practitioner from an operation, or a group of operations, performed on a patient at the same time, other than a bone marrow biopsy; and

(b) if:

(i) a pathology service that is the examination of biopsy material is rendered under any of those items; and

(ii) a further pathology service mentioned in any of those items is also rendered using that biopsy material;

those pathology services are treated as 1 pathology service.


 

10. For the purposes of items 73041 to 73280 (inclusive), “serial examinations” means examinations requested on 1 occasion whether or not:

(a) the materials are received on different days by the approved pathology practitioner; or

(b) the examinations were requested on 1 or more request forms by the treating practitioner.

 

11. (1) For the purposes of this rule and items 73901 to 73921 (inclusive):

“approved pathology authority has the same meaning as in Division 4a of Part IIA of the Act;

“institution” means a place (other than a hospital, a nursing home or accommodation for aged persons that is attached to a nursing home or situated within a nursing home complex) at which residential accommodation or day care is, or both residential accommodation and day care are, made available to:

(a) disadvantaged children; or

(b) juvenile offenders; or

(c) aged persons; or

(d) chronically ill psychiatric patients; or

(e) homeless persons; or

(f) unemployed persons; or

(g) persons suffering from alcoholism; or

(h) persons addicted to drugs; or

(i) physically or mentally handicapped persons.

“licensed collection centre” has the same meaning as in Part IIA of the Act;

“prescribed laboratory” means a laboratory operated by:

(a) the Commonwealth; or

(b) a State; or

(c) an authority of a State or Territory; or

(d) the Northern Territory; or

(e) the Australian Capital Territory; or

(f) an Australian tertiary education institution.

“specimen collection centre” has the same meaning as in Part IIA of the Act;

“temporary collection centre” has the same meaning as in Part IIA of the Act;

“treating practitioner” has the same meaning as in paragraph 16a (1) (a) of the Act.

(2) A service mentioned in items 73901 to 73921 (inclusive) applies to a pathology service when rendered by, or on behalf of, an approved pathology practitioner who is a recognised pathologist unless:

(a) the service is rendered upon a request made in the course of an outpatient service at a recognised hospital; or

(b) the service is rendered upon a request made for a patient who is a private patient in a recognised hospital when the request was made; or


 

(c) the pathology equipment of a recognised hospital, or prescribed laboratory, is used in rendering the service; or

(d) a member of the staff of a recognised hospital, or prescribed laboratory, participates in the service in the course of the member’s employment with the hospital or laboratory.

 

(3) A service mentioned in items 73901 to 73921 (inclusive) does not apply to a pathology service to which subsection 16A (7) of the Act applies.

 

(4) If one item of items 73901 to 73917 (inclusive) applies to a patient episode, none of the remainder of those items apply to that patient episode.

 

(5) Item 73921:

(a) applies only to the approved pathology practitioner or approved pathology authority to whom the specimen mentioned in the item was referred; and

(b) applies to a service even if any item in items 73901 to 73917 (inclusive) also applies to the service.

 

12. The abbreviations at the end of the table may be used to identify particular pathology services or groups of pathology services.


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

 

GROUP PI - HAEMATOLOGY

 

65001

Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count - one or two procedures

5.40

65003

Three or more procedures to which item 65001 applies, including any calculation or measurement of erythrocyte or other indices

7.40

65005

Examination of blood film, with or without five part differential cell count, or five part differential cell count with or without examination of blood film, and if performed, any of these additional services -Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027

9.70

65007

Full blood examination consisting of items 65003 and 65005

16.40

65009

Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - one or more procedures

22.50

65011

Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and two of the following - examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001, 65003, 65005 and 65007

35.00

65013

Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any services specified in items 65001, 65003, 65005, 65007 and 65015

108.00

65015

Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any services specified in items 65001, 65003, 65005 and 65007

78.00

65017

Blood grouping, including back-grouping when performed - ABO and Rh (D antigen)

9.50

65019

Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 65017

18.80


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

65021

Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001, 65003, 65005 and 65007

35.00

65023

Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001, 65003, 65005, 65007, 65017 and 65021 including all testing performed on any one day

86.00

65025

Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected

15.60

65027

Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm’s test) including those services specified in items 65005 and 65007 - one or more tests

8.60

65029

Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or one of - fibrinogen degradation products, fibrin monomer or D-dimer - one estimation

11.80

65031

Two estimations specified in item 65029

15.70

65033

Three estimations specified in item 65029

19.60

65035

Four or more estimations specified in item 65029

23.50

65037

Quantitative assay, by one or more techniques, of plasminogen, anti thrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant - one estimation

23.50

65039

Four or more estimations specified in item 65037

74.00

65041

Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations

46.50

65043

Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin - one or more estimations

31.00

65045

Quantitative assay of Von Willebrand’s factor antigen (factor VIA related antigen), Von Willebrand’s factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor - one estimation

31.00

65047

Two estimations as specified in item 65045

44.50

65049

Three or more estimations as specified in item 65045

58.00


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

 

GROUP P2 - CHEMICAL

 

66201

Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of - alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - one estimation

9.60

66203

Two estimations specified in item 66201

11.60

66205

Three estimations specified in item 66201

13.60

66207

Four estimations specified in item 66201

15.60

66209

Five estimations specified in item 66201

17.60

66211

Six or more estimations specified in item 66201

19.10

66213

Qualitative estimation by any method, except by reagent strip or dip-stick of the followingurine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - one or more estimations

9.30

66217

Qualitative estimation by any method except by reagent strip or dipstick of the following faecal constituents - haemoglobin, porphyrins, reducing substances - each estimation, to a maximum of three estimations, taken on separate days

6.20

66219

Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217 - one estimation in any twenty eight day period

11.80

66223

Osmolality, estimation by osmometer, in serum or in urine - one or more estimations

23.50

66225

Quantitative estimation of blood gases including tests performed from - pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen _ one or more estimations on one specimen

32.00

66227

Estimation of blood gases as specified in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any one day

8.40

66229

Calculus, analysis of one or more

29.00


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

66231

Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances - one or more assays

39.00

66233

Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes - each assay to a maximum of four assays within any twenty eight day period

19.60

66235

Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule - one estimation

19.60

66237

Two estimations specified in item 66235

27.30

66239

Three or more estimations specified in item 66235

35.00

66243

Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid - one or more examinations or estimations

31.00

66245

Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5mmol/l and Triglyceride >3.0 mmol/1 or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity - one examination to a maximum of two examinations in any twelve month period

29.00

66247

Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a twenty eight day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity - two or more examinations

43.00


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

66251

Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-l esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 66263), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphotase, Transferrin (unless specified in item 66263), and, in the follow up of proven malignancy, Mucin-like carcinoma associated antigen, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, Thyroglobulin - quantitative estimation in serum, urine or other body fluid - one estimation

18.80

66253

Two or more estimations specified in item 66251

35.00

66263

Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin

37.00

66265

Serum B12, serum folate - one or more estimations within any twenty eight day period

23.50

66267

Red cell folate and serum B12 and, if required, serum folate, to a maximum of three estimations in any twelve month period

42.50

66269

Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period

29.00

66271

Vitamin D or D fractions - one or more estimations

29.00

66273

Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (one or more fractions), oxalate, pyruvate, serotonin, xylose, zinc - one quantitative estimation

23.50

66275

Two or more estimations specified in item 66273

36.50

66277

Aluminium, arsenic, beryllium, cadium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period

33.00

66279

Blood lead estimation, other than for occupational health screening purposes, to a maximum of three estimations in any six month period - each estimation

29.00

66281

Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations

37.50

66283

Faecal fat, Breath Hydrogen measurements in response to loading with disaccharides - one or more quantitative estimations within any twenty eight day period

37.50


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

66285

Solid tissue or tissues excluding blood elements - assay of one or two enzymes

37.50

66287

Assay of three to five enzymes as specified in item 66285

70.00

66289

Assay of six or more enzymes as specified in item 66285

93.00

66291

Thyroid function tests, including thyrotrophin (TSH) and at least one or more of the following tests - free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin

39.00

66293

Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones

46.50

66295

Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, L-Dopa stimulation of growth hormone, where physically performed by a recognised pathologist - one or more procedures

11.00

66297

Gonadotrophin releasing hormone stimulation test, Synacthen stimulation test, Glucagon stimulation test with C-peptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologist - one procedure

37.00

66299

Two or more tests specified in item 66297

59.00

66301

Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, .Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti diuretic hormone) - one estimation

30.00

66303

Two estimations specified in item 66301

40.60

66305

Three estimations specified in item 66301

51.20

66307

Four estimations specified in item 66301

61.80

66309

Five estimations specified in item 66301

72.40

66311

Six or more estimations specified in item 66301

83.00

66315

Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast - one or more assays

76.00

66317

HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs - each estimation to a maximum of four estimations in any twelve month period

11.80


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

66319

Glycosylated haemoglobin only when performed in the management of established diabetes - each estimation to a maximum of four estimations in any twelve month period

15.80

GROUP P3 - MICROBIOLOGY

69201

Microscopic examination of material other than blood, from one or more sites, obtained directly from a patient and excluding material from cultures - wet film, inlcuding differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains - one or more examinations

7.00

69203

Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of three estimations taken on separate days including any services specified in item 69201 - each estimation

11.80

69205

The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201 - one or more sites

18.40

69207

Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites - skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201 and 69205 - one or more examinations on one or more specimens

27.00

69209

Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 69207 - one or more sites

36.50


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

69211

Cultural examination (including the detection of Clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least two selective or enrichment media as well as culture in at least two different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201, to a maximum of three specimens in any seven day period - each examination

44.50

69213

Microscopy with appropriate stains and cultural examinations of three specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201

62.00

69215

Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of three sets

16.20

69217

Urine examination including serial examination, with cell count, relevant stained preparations, cultur, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (Simple culture by dip slide is excluded from this item)

19.00

69219

Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211 has been performed - one or more estimations

15.60

69221

Direct detection of Chlamydia from clinical material, not cultures -one or more estimations

9.30

69223

Direct detection of Herpes simplex from clinical material, not cultures - one or more estimations

9.30

69225

Investigation for Herpes simplex virus (one or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by one or more cultural methods, including any services specified in items 69221 and 69223

27.00

69227

All microbiological serology during pregnancy, which must include the determination of Rubella immune status, syphilis serology and Hepatitis B surface antigen and including all services in Items 69229, 69243 and 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy

27.00


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

69229

Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody

13.30

69231

Two estimations specified in item 69229

20.30

69233

Three estimations specified in item 69229

27.30

69235

Four estimations specified in item 69229

34.30

69237

Five estimations specified in item 69229

41.30

69239

Six or more estimations specified in item 69229

48.30

69243

Hepatitis B surface antigen test

13.20

69245

Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including services specified in items 69243, 69247 and 69249

17.80

69247

All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in items 69243, 69245 and 69249

35.00

69249

All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in items 69243 and 69245

25.50

69251

Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations

23.50

GROUP P4 - IMMUNOLOGY

71001

Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures

29.00

71003

Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005) on serum and urine concurrently collected -two or more procedures

43.00

71005

Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method- estimation of one immunoelobin

14.00

71007

Two estimations specified in item 71005

21.70

71009

Three or more estimations specified in item 71005

29.40

71011

Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA - one or more estimations

43.00


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

71013

Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period

24.50

71015

Specific IgG or IgE antibodies to potential allergens - one or more tests for single or multiple allergens with a maximum of four estimations in any twelve month period

22.50

71017

Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required

23.50

71019

Measurment of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained

28.50

71021

Antibodies to extractable nuclear antigens, detection of in serum or other body fluids

19.60

71023

Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 71021

31.00

71025

Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody

23.00

71027

Two estimations specified in item 71025

27.00

71029

Three estimations specified in item 71025

31.00

71031

Four or more estimations specified in item 71025

35.00

71033

Rheumatoid factor, detection of by any technique

9.30

71035

Quantitation of Rheumatoid factor where detected, including services specified in item 71033

18.40

71037

Complement - total and components - one quantitative estimation

15.40

71039

Two estimations as specified in item 71037

23.10

71041

Three or more estimations as specified in item 71037

30.80

71043

Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests

29.00

71045

Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Group P1 - Haematology in the Schedule

48.50

71047

Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniquesto assess lymphoid populations using a minimum of three monoclonal antibodies, including any services in item 71049 - one or more estimations

62.00

71049

Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techiques in the investigation of a probable haematological malignancy using a minimum of seven monoclonal antibodies, including any services in item 71047 - one or more estimations

148.00

71051

HLA typing comprising A, B, C and DR phenotypes

66.00


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

71053

HLA typing, excluding any services specified in item 71051 - one or more antigens

27.00

71055

Mantoux test

9.30

GROUP P5 - HISTOPATHOLOGY

72801

Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions

75.00

72803

Immediate frozen section diagnosis of biopsy material, including any other histopathology examination

122.00

72805

Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination

93.00

72807

Electron microscopy of biopsy material including any other histopathology examination

99.00

 

GROUP P6 - CYTOPATHOLOGY

 

73043

Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations

14.40

73045

Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 73043 and any histopathological service performed on that cytology specimen - one or more examinations

28.00

73047

Cytological examination including examination of a series of three sputum or urine specimens for malignant cells

58.00

73049

Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues

35.00

73051

Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance

66.00

73053

Routine cytological examination of smears from cervix for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear - each examination

12.00


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

73055

Cytological examination of smears from cervix in association with the management of previously detected abnormalities including precancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with Item 73053 -each examination

12.00

73057

Cytological examination of smears from vagina, not associated with Items 73053 or 73055 - each examination

12.00

GROUP P7 - CYTOGENETICS

73281

Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations

128.00

73283

Chromosome studies, including preparation, count and karyotyping of blood

116.00

73285

Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications

99.00

GROUP P8 - INFERTILITY AND PREGNANCY TESTS

73521

Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner’s test)

6.50

73523

Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month period

27.00

73525

Sperm antibodies, sperm penetrating ability - one or more tests

17.40

73527

Chorionic gonadotrophin (beta - HCG), qualitative estimation in serum or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations

9.50

73529

Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion

27.00

GROUP P9 - SIMPLE BASIC PATHOLOGY TESTS

73801

Seminal examination for presence of spermatozoa

6.20


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

73802

Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - one procedure

4.15

73803

Two procedures specified in item 73802

6.20

73804

Three or more procedures specified in item 73802

8.25

73805

Microscopical examination of urine

4.15

73806

Pregnancy test by one or more immunochemical methods

10.15

73807

Microscopical examination of wet film other than urine

6.20

73808

Microscopical examination of gram stained film

7.85

73809

Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method

2.10

73810

Microscopical examination screening for fungi in skin, hair or nails -one or more sites

6.20

73811

Mantoux test

10.15

GROUP P10 - PATIENT EPISODE INITIATION

73901

Initiation of a patient episode by collection of specimen for a service specified in item 73053, 73055 or 73057 from a person who is not in a recognised hospital or a prescribed laboratory

7.50

73903

Initiation of a patient episode by collection of specimen for a service specified in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital

13.50

73905

Initiation of a patient episode by collection of specimen for a service specified in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital

7.50

73907

Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a licensed collection centre other than a temporary licensed collection centre

15.50

73909

Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital

15.50


SCHEDULE- continued

Item

Pathology service

Fee

 

 

$

73911

Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority, from a person in the place where the person was residing or in a nursing home or institution

15.50

73913

Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905, 73907 and 73801 to 73811 (inclusive) where the specimen is collected from the person by the person

9.50

73915

Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by or on behalf of the treating practitioner

9.50

73917

Patient episode initiated by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a temporary licensed collection centre

9.50

GROUP P11 - SPECIMEN REFERRED

73921

Referral of specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority

9.50


ABBREVIATIONS

A. ABBREVIATIONS FOR GROUPS OF TESTS

Group

Estimations

Included in Group

Abbreviation

Item Numbers

Cardiac Enzymes

Lactate dehydrogenase (LDH)

Aspartate aminotransferase (AST) and

Creatine kinase (CK)

CE

66205/66206

Coagulation Studies

Prothrombin Time, activated partial thromboplastin time and two or more of the following tests-bleeding time, thrombin clotting time, fibrinogen degradation products, fibrin monomer, D-dimer Factor XIII screening tests.

COAG

65035/65036

Electrolytes

Sodium (NA)

Potassium (K)

Chloride (CL) and

Bicarbonate (HCO3)

E

66207/66208

Lipid Studies

Cholesterol (CHOL) and Triglycerides (TRIG)

FATS

66203/66204

Liver

Alkaline phosphatase (ALP),

LFT

66211/66212

Function

Alanine aminotransferase

 

 

Tests

(ALT),

Aspartate aminotransferase (AST),

Albumin (ALB),

Bilirubin (BLL),

Gamma glutamyl transpeptidase (GGT),

Lactate dehydrogenase (LDH), and Protein (PROT).

 

 


A. ABBREVIATIONS FOR GROUPS OF TESTS - continued

Group

Estimations

Included in Group

Abbreviation

Item Numbers

Syphilis

Rapid plasma reagin test

STS

69231/69232

Serology

(RPR) or venereal disease research laboratory test (VDRL) and Treponema pallidum haemagglutin test (TPHA) or Fluorescent Treponemal antibody-absorption test (FTA)

 

 

Urea,

Urea,

U&E

66205/66206

Electrolytes,

Electrolytes,

 

 

Creatine

Creatine

 

 

 

 

 

 

 


B. ABBREVIATIONS FOR INDIVIDUAL TESTS

Approved item name of test in Schedule

Abbreviation

Item Number

Abnormal haemoglobins

AH

65027,65028

Acetoacetate

ACAT

66273,66274

Acetylated Sulphadimidine

ASUL

66235,66236

Adrenocorticotrophic hormone

ACTH

66301,66302

AFB Microscopy and culture of Sputum

AFB

69213,69214

Alanine Aminotransferase

ALT

66201,66202

Albumin

ALB

66201,66202

Alcohol (Ethanol)

ETOH

66273,66274

Aldosterone

ALD

66301,66302

Alkaline Phosphatase

ALP

66201,66202

Phosphatase Isoenzymes

ALPI

66245,66246

Alpha feto protein

AFP

66251,66252

Alpha-1 antitrypsin

A AT

66251,66252

Alpha-2 macroglobulin

AMAC

66251,66252

Aluminium

AL

66277,66278

Amiodarone

AMIO

66235,66236

Amitriptyline

AMIT

66235,66236

Ammonia

NH3

66273,66274

Amniotic Fluid Examination

AFE

66243,66244

Amylase

AMS

66201,66202

Amylobarb

AMYL

66235,66236

Androstenedione

ANDR

66301,66302

Angiotensin converting enzyme

ACE

66273,66274

Antibiotic & antimicrobial chemotherapeutic agents, quantitative assay

 

 

QAA

69251,69252

Antibodies to

 

 

Extractable Nuclear Antigens - detection

ENA

71021,71022

Extractable Nuclear Antigens - characterization of antibodies if positive ENA

 

 

ENAP

71023,71024

Nuclear Antigens - detection

ANA

71017,71018

Nuclear Antigens-quantitation & measurement of DNA binding if positive ANA

 

 

ANAP

71019,71020

Tissue Antigens:

 

 

Acetylcholine Receptor

ARA

71025,71026

Adrenal cell

ADR

71025,71026

Cardiolipin

ACL

71025,71026

Centromere

ACA

71025,71026

Gastric parietal cell

PCA

71025,71026

Gliadin IgA

GLIA

71025,71026

Glomerular basement membrane

GBA

71025,71026

Insulin Receptor Antibodies

INSA

71025,71026

Intercellular cement substance of skin

ICCS

71025,71026

Jo-1

JO1

71025,71026


 

Approved item name of test in Schedule

Abbreviation

Item Number

Keratin

KERA

71025,71026

Liver/Kidney microsomes

LKA

71025,71026

Mitochondria

MA

71025,71026

Parathyroid

PTHA

71025,71026

PM-1

PM1

71025,71026

Reticulin

RCA

71025,71026

Skeletal muscle

SLA

71025,71026

Skin basement membrane

SKA

71025,71026

Smooth muscle

SMA

71025,71026

SCL 70

SCL

71025,71026

Thyroid Microsomal

TMA

71025,71026

TSH Receptor Antibody test

TSHA

71025,71026

Antibody Testing, Microbial

 

(see Microbial)

Antigen Testing, Microbial

 

(see Microbial)

Antithrombin III

ATH

65037,65038

Arginine

ARLN

66297,66298

Arsenic

AS

66277,66278

Aspartate Aminotransferase

AST

66201,66202

Barbitone

BARB

66235,66236

Beryllium

BE

66277,66278

Beta Hydroxybutyrate

BHYB

66273,66274

Beta-2 microglobulin

BMIC

66251,66252

Bicarbonate

HCO3

66201,66202

Bilirubin (all fractions)

BILI

66201,66202

(Neonatal)

BILN

66273,66274

Bleeding Time

BT

65029,65030

Blood Culture

BC

69215,69216

Film

BF

65005,65006

Gases

GAS

66225,66228

Group and blood group antibodies

BGAB

65021,65022

Group Antibodies

BGA

65025,65026

Group Systems

BGS

65019,65020

Grouping-ABO and RH (D antigen)

BG

65017,65018

Bone Marrow Examination - Aspirate

BMEA

65015,65016

- Trephine

BMET

65013,65014

Breath Hydrogen test

BHT

66283,66284

Bromide

BRMD

66235,66236

Butobarb

BUTO

66235,66236

C-1 esterase inhibitor

CEI

66251,66252

C-Peptide

CPEP

66301,66302

C-reative protein

CRP

65001,65002

CA-125 antigen

C125

66251,66252

CA-15.3 antigen

CA15

66251,66252

CA-19.9 antigen

CA19

66251,66252


 

Approved item name of test in Schedule

Abbreviation

Item Number

Cadmium

CP

66277,66278

Caeruloplasmin

CPLS

66251,66252

Calcitonin

CALT

66301,66302

Calcium (total, dialysed or ionized)

CA

66201,66202

Calculus Analysis

CALC

66229,66230

Carbamazepine (Tegretol)

CARB

66235,66236

Carboxyhaemaglobin

COHB

65027,65028

Carcinoembryonic antigen

CEA

66251,66252

Catecholamines

CAT

66281,66282

Chlamydia Investigation by Cultural Methods

CHLC

69225,69226

Chloral Hydrate

CHHY

66235,66236

Chlorazepate

CHZP

66235,66236

Chloride

CL

66201,66202

Chloroquine

CLOQ

66235,66236

Chlorpromazine

CHLO

66235,66236

Cholesterol

CHOL

66201,66202

Cholinesterase

CHSE

66273,66274

Chorionic gonadotrophin for pregnancy diagnosis

HCG

73527,73528

- for diagnosis of specified conditions

HCGD

73529,73530

Chromium

CR

66277,66278

Chromosome indentiflcation by banding technique

CSI

73285,73286

studies

CS

73281,73282

studies of blood

CSB

73283,73284

Cimetidine

CMTD

66235,66236

Clobazam

CLOB

66235,66236

Clonazepam (Rivotril)

CLON

66235,66236

Clostridium difficile

CLDT

69219,69220

Coagulation factors (see individual factors) time

CT

65029,65030

Cold Agglutinins

CAG

65027,65028

Collection of specimen (s) for cytological examination

 

 

73053,73055,

73057,73901,

73903,73905,

73907,73909

Compatibility testing

XMAT

65023,65024

Complement Total, C3 or C4

COM

71037,71038

(Other complements must be specified)

 

 

Copper

CU

66277,66278

Cortisol

CORT

66301,66302

Creatine Kinase

CK

66201,66202

Kinase Isoenzymes

CKI

66201,66202

Kinase Isoenzymes (electrophoresis)

CKIE

66245,66246

Creatinine

C

66201,66202


 

Approved item name of test in Schedule

Abbreviation

Item Number

Cryofibrinogen

CFIB

66213,66214

Cryoglobulins

CGLB

66213,66214

Cryptococcal antigen

CRYN

69219,69220

CSF antigens

 

 

- Haemophilus influenzae

CSFA

69219,69220

- Streptococcus pneumoniae

CSFA

69219,69220

- Neisseria meningitidis

CSFA

69219,69220

- Group B streptococcus

CSFA

69219,69220

Cultural Examination of Faeces

FCS

69211,69212

Cyclic AMP

CAMP

66301,66302

Cyclosporin A

CLSA

66235,66236

Cysteine (see Urine Cystine)

UCYS

66213,66214

Cystine (cysteine)

CYST

66273,66274

Cytology from body fluids, sputum (1 specimen), urine, washings or brushings

 

 

BFCY

73045,73046

- from cervix

CCR

73053,73054,

 

 

73055,73056

- from fine needle aspiration of solid tissues

FNCY

73049,73050

- from fine needle aspiration of solid tissues aspiration or attendance by a pathologist

 

 

FNCP

73051,73052

- from skin, nipple discharge, lip, mouth, nose or anus

SMCY

73043,73044

- from vagina

CVO

73057,73058

- from 3 sputum or urine specimens

SPCY

73047,73048

D-dimer test

DD

65029,65030

Dehydroepiandrosterone sulphate

DHEA

66301,66302

Deoxycortisol

DCOR

 

Desethyl Amiodarone

DEAM

66235,66236

Desipramine

DESI

66235,66236

Dexamethasone

DXST

66295,66296

Suppression test

DEXA

66301,66302

Diazepam

DIAZ

66235,66236

Differential Cell Count

DIFF

65005,65006

Digoxin

DIG

66235,66236

Dihydrotestosterone

DHTS

66301,66302

Diphenylhydantion (Dilantin)

DLL

66235,66236

Direct Coombs test

CMBS

65027,65028

Disopyramide (Rythmodan)

DISO

66235,66236

Doxepin

DOXE

66235,66236

Drug abuse treatment programme assay therapeutic -

 

 

DRGA

66233,66234

(drugs not listed must be written in full)

 

(see each drug)

or Chemical Assays - Overdose

DRGO

66231,66232

Electron microscopy of biopsy material

EM

72807,72808


 

Approved item name of test in Schedule

Abbreviation

Item Number

Electrophoresis, to demonstrate

 

 

- protein classes, or paraprotein

EPP1

66245,66246

- protein classes or presence and amount of paraprotein classes, concurrent collection

EPP2

66247,66248

Elements (see individual elements)

 

 

Enzyme assays of solid tissue or tissues

ENZS

66285,66286

Erythrocyte assessment of Haemolysis

ERYH

65009,65010

assessment of Metabolic Enzymes

ERYM

65009,65010

count

RCC

65001,65002

sedimentation rate

ESR

65001,65002

Ethosuximide (Zarontin)

ETHO

66235,66236

Euglobulin clot lysis time

ECLT

65037,65038

Factor II

FII

65045,65046

V

FV

65045,65046

VII

FVII

65045,65046

VIII

VIII

65045,65046

IX

FIX

65045,65046

X

FX

65045,65046

XI

FXI

65045,65046

XII

FXII

65045,65046

XIII

XIII

65045,65046

XIII deficiency test

F13D

65029,65030

Faecal Fat

FFAT

66283,66284

Haemoglobin (chemical test)

FHC

66217,66218

Haemoglobin (immunological test)

FHI

66219,66220

Porphyrins (qualitative test)

FPR

66217,66218

Reducing Substances

FRS

66217,66218

Ferritin (see also Iron Studies)

FERR

66251,66252

Fibrin Monomer

FM

65029,65030

Fibrinogen

FIB

65029,65030

Degradation Products

FDP

65029,65030

Fitzgerald Factor

FGF

65045,65046

Flecainide

FLEC

66235,66236

Fletcher Factor

FF

65045,65046

Follicular Stimulating Hormone

FSH

66301,66302

Fructosamine

FRUC

66201,66202

Full Blood Examination

FBE

65007,65008

Gamma Glutamyl Transpeptidase

GGT

66201,66202

Gastrin

GAST

66301,66302

Globulin

GLOB

66201,66202

Glucagon

GSTC

66297,66298

Glucagon

GLGO

66301,66302

Glucose

GLUC

66201,66202

Tolerance Test

GTT

66201,66202


 

Approved item name of test in Schedule

Abbreviation

Item Number

Glycosylated Haemoglobin (Hb Ale)

GHB

66319,66320

Gold

AU

66277,66278

Gonadotrophin

GRHS

66297,66298

Growth Hormone

GH

66301,66302

Hormone-exercise

GHSE

66295,66296

Hormone-glucose

GHSG

66295,66296

Haematocrit

HCT

65001,65002

Haemoglobin Estimation

HB

65001,65002

Haemoglobinopathy tests

HMGP

65011,65012

Haptoglobins

HGLB

66251,66252

HDL Cholesterol

HDLC

66317,66318

Heparin Cofactor II

HRNC

65037,65038

Estimation

HEPR

65043,65044

Hepatitis Serology

 

 

Acute hepatitis

HEP

69247,69248

Follow-up of proven Hepatitis B

HEPB

69249,69250

Hepatitis B Serology to define immune status

HEPI

69245,69246

Hepatitis B surface Antigen HBsAg

HBSA

69243,69244

Herpes simplex Virus Investigation

 

 

by Cultural Methods

HSVC

69225,69226

Heterophile Antibodies

IM

65027,65028

HIAA (Hydroxyindoleacetic acid)

HIAA

66273,66274

Histamine

HIAM

66273,66274

Histopathology of biopsy material

HIST

72801,72802

HLA Typing, comprimising A,B,C and DR phenotypes

HLA

71051,71052

Typing, one or more antigens

HLAN

71053,71054

HMMA (Hydroxy Methoxy Mandelic acid -previously known as VMA)

HMMA

66281,66282

Homovanillic acid

HVA

66281,66282

Hormone Receptor Assay

HRA

66315,66316

Ovarian

HRO

66315,66316

Hormones:

 

 

Adrenocorticotrophic hormone

ACTH

66301,66302

Aldosterone

ALDS

66301,66302

Androstenedione

ANDR

66301,66302

C-Peptide

CPEP

66301,66302

Calcitonin

CALT

66301,66302

Cortisol

CORT

66301,66302

Cyclic AMP

CAMP

66301,66302

Dehydroepiandrosterone sulphate

DHEA

66301,66302

Dihydrotestosterone

DHTS

66301,66302

Follicular Stimulating Hormone

FSH

66301,66302

Gastrin

GAST

66301,66302


 

Approved item name of test in Schedule

Abbreviation

Item Number

Glucagon

GSTC

66297,66298

Glucagon

GLGO

66301,66302

Gonadotrophin

GRHS

66297,66298

Growth Hormone

GH

66301,66302

Growth Hormone-exercise

GHSE

66297,66298

Growth Hormone-glucose

GHSG

66297,66298

Hormone Receptor Assay

HRA

66315,66316

Human Placental Lactogen

HPL

66301,66302

Hydroxyprogesterone

OHP

66301,66302

Insulin

INS

66301,66302

Insulin

INHY

66297,66298

Luteinizing Hormone

LH

66301,66302

Oestradiol

E2

66301,66302

Oestriol

E3

66301,66302

Oestrone

E1

66301,66302

Parathyroid Hormone

PTH

66301,66302

Pentagastrin

PSTR

66297,66298

Progesterone

PROG

66301,66302

Prolactin

PROL

66301,66302

Renin

REN

66301,66302

Sex Hormone Binding globulin

SHBG

66301,66302

Somatomedin

SOMA

66301,66302

Testosterone

TES

66301,66302

Thyroid stimulating hormone (where not requested as part of TFTs)

TSH

66301,66302

Urine Steroid Fraction or Fractions

USF

66301,66302

Vasoactive Intestinal Peptide

VIP

66301,66302

Vasopressin

ADH

66301,66302

11 Deoxycortisol

DCOR

66301,66302

Huhner’s test

HT

73521,73522

Human placental lactogen

HPL

66301,66302

HVA (Homovanillic acid)

HVA

66281,66282

Hydroxproline

HYDP

66273,66274

Hydroxy Methoxy Mandelic acid

 

 

(previously known as VMA)

HMMA

66281,66282

Hydroxychloriquine

HOCQ

66235,66236

Hydroxyindoleacetic acid

HIAA

66273,66274

Hydroxyprogesterone

OHP

66301,66302

Imipramine

IMIP

66235,66236

Immediate frozen section diagnosis of biopsy material

FS

72803,72804

Immunoglobulins £

IGE

71013,71014

G, A, M or D

IG

71005,71006

G, Subclasses 1-4

SIGG

71011,71012


 

Approved item name of test in Schedule

Abbreviation

Item Number

Immunohistochemical investigation of biopsy material

IHIS

72805,72806

Insulin

INHY

66297,66298

Insulin

INS

66301,66302

Intestinal disaccharidases

INTD

66285,66286

Iron

(see Iron Studies)

Iron Studies (Iron, Transferrin and Ferritin)

IS

66263,66264

L-DOPA

GHLD

66295,66296

Lactate

LACT

66273,66274

Dehydrogenase

LDH

66201,66202

Dehydrogenase Isoenzymes

LDI

66245,66246

Lamellar body phospholipid

LBPH

66243,66244

Lead

PB

66279,66280

Lecithin/Sphingomyelin Ratio (Amniotic fluid)

LS

66243,66244

Leucocyte Count

WCC

65001,65002

Fractionation

LF

71043,71044

Functional tests

LFF

71045,71046

Surface markers in investigation of probable haematological malignancy

LSMH

71049,71050

Surface Markers to assess lymphoid populations

LSML

71047,71048

Lignocaine

LIGN

66235,66236

Lipase

LIP

66201,66202

Lithium

LI

66201,66202

Lupus Anticoagulant

LUPA

65037,65038

Luteinizing Hormone

LH

66301,66302

Magnesium

MG

66201,66202

Mammary serum antigen

MSA

66251,66252

Manganese

MN

66277,66278

Mantoux Test

MANT

71055,71056

Melanogen (see Urine Melanin)

UML

66213,66214

Mercury

HG

66277,66278

Metalbumin detection (Schumm’s test)

SCHM

65027,65028

Metanephrines

MNEP

66281,66282

Methadone

MTDN

66235,66236

Methotrexate

MTTA

66235,66236

Methoxy Hydroxy Phenyethylene Glycol

MHPG

66281,66282

Methsuximide

MSUX

66235,66236

Metronidazole

MRDZ

66235,66236

Mexiletine (Mexitil)

MEX

66235,66236

MHPG (Methoxy Hydroxy Phenyethylene Glycol)

MHPG

66281,66282

Microalbumin

MALB

66251,66252

Microbacteria Microscopy and culture of Sputum

AFB

69213,69214


 

Approved item name of test in Schedule

Abbreviation

Item Number

Microbial Antibody Testing

 

 

Actinomycetes

ACT

69229,69230

Adenovirus

ADE

69229,69230

Aspergillus

ASP

69229,69230

Avian precipitins (Bird Fancier’s Disease)

APP

69229,69230

Blastomyces

BLM

69229,69230

Bordetella pertussis

BOR

69229,69230

Borrelia berghoffer

BOB

69229,69230

Brucella

BRU

69229,69230

Campylobacter jejuni

CAM

69229,69230

Candida

CAN

69229,69230

Chlamydia

CHL

69229,69230

Coccidioides

CCC

69229,69230

Coxsackie Bl-6

COX

69229,69230

Cryptococcus

CRY

69229,69230

Cytomegalovirus

CMV

69229,69230

Cytomegalovirus serology in pregnancy

CMVP

69227,69228

Dengue

DEN

69229,69230

Diptheria

DIP

69229,69230

Echinococcus

ECC

69229,69230

Echo-coxsakie group

ECH

69229,69230

Entamoeba Histolytica

AMO

69229,69230

Epstein Barr Virus

EBV

69229,69230

Fluorescent Treponemal antibody

 

 

- absorption test (FTA-ABS)

FTA

69229,69230

Haemophilus

HUS

69229,69230

Hepatitis delta antibody - Anti-delta

HDA

69229,69230

Histoplasma

HIP

69229,69230

Hydatid

HYD

69229,69230

Influenza A

FLA

69229,69230

Influenza B

FLB

69229,69230

Legionella pneumophila - Serogroup 1

LP1

69229,69230

Legionella pneumophila - Serogroup 2

LP2

69229,69230

Leishmaniasis

LEI

69229,69230

Leptospira

LEP

69229,69230

Listeria

LIS

69229,69230

Measles

MEA

69229,69230

Micropolyspora faeni

MIC

69229,69230

Mumps

MUM

69229,69230

Murray Valley Encephalitis

MVE

69229,69230

Mycoplasma pneumoniae

MYC

69229,69230

Neisseria gonorrhoea

GON

69229,69230

Newcastle Disease

NCD

69229,69230

Parainfluenza 1

PF1

69229,69230


 

Approved item name of test in Schedule

Abbreviation

Item Number

Parainfluenza 2

PF2

69229,69230

Parainfluenza 3

PF3

69229,69230

Paratyphi

PTY

69229,69230

Pertussis

PER

69229,69230

Pneumococcus

PCC

69229,69230

Poliomyelitis

PLO

69229,69230

Proteus OX 19

POX

69229,69230

Proteus OXK

POK

69229,69230

Q fever

QFF

69229,69230

Rapid Plasma Reagin test

RPR

69229,69230

Respiratory Syncytial Virus

RSV

69229,69230

Ross River Virus

RRV

69229,69230

Rubella

RUB

69229,69230

Rubella Serology in Pregnancy

MSP

69227,69228

Salmonella typhi (H)

SAH

69229,69230

Salmonella typhi (0)

SAO

69229,69230

Schistosoma

STO

69229,69230

Streptococcal Serology - Anti-D-NASE B titre

ADNB

69229,69230

Streptococcal Serology-Anti-streptolysin O titre

ASOT

69229,69230

Tetanus

TET

69229,69230

Thermoactinomyces vulgaris

THE

69229,69230

Thermopolyspora

TPS

69229,69230

Toxocara

TOC

69229,69230

Toxoplasma

TOX

69229,69230

Toxoplasma serology in pregnancy

TOXP

69227,69228

TPHA (Treponema pallidum haemagglutin test)

TPHA

69229,69230

Treponema pallidum haemagglutin test

TPHA

69229,69230

Trichonosis

TOS

69229,69230

Typhus, Weil-Felix

TYP

69229,69230

Varicella zoster

VCZ

69229,69230

VDRL (Venereal Disease Research Laboratory)

VDRL

69229,69230

Yersinia enterocolytica

YER

69229,69230

Microbial Antigen Testing

 

 

Chlamydia

CHLY

69221,69222

Herpes simplex Virus

HSV

69223,69224

Varicella Zoster

VCZN

69219,69220

Micropolyspora faeni

MIC

69229,69230

Microscopic examination of faeces for parasites

OCP

69203,69204

examination of material other than blood

M

69201,69202


 

Approved item name of test in Schedule

Abbreviation

Item Number

Microscopy and culture of

 

 

- material from nose, throat, eye or ear

MCS1

69205,69206

- material from skin, superficial sites, urethra, vagina, cervix or rectum

MCS2

69207,69208

- post-op wounds, aspirations of body cavities, synovial fluid, CSF, op/biopsy specimens

MCS3

69209,69210

- specimens of sputum

MCS2

69207,69208

- specimens of sputum, urine or other

body fluids for mycobacteria

AFB

69213,69214

Mucin like carcinoma associated antigen

MCA

66251,66252

N-Acetyl Procainamide

NAPC

66235,66236

N-Desalkyldothiepin

NDOT

66235,66236

N-Desalkyl Clobazam

NDAC

66235,66236

Doxepin

NDAD

66235,66236

Neuron specific enolase

NSEN

66251,66252

Nickel

NI

66277,66278

Nitrazepam

NITR

66235,66236

Nordothiepin

NDIP

66235,66236

Nortriptyline

NORT

66235,66236

Oestradiol

E2

66301,66302

Oestriol

E3

66301,66302

Oestrone

E1

66301,66302

Osmolality, Serum or Urine

OSML

66223,66224

Oxalate

OXAL

66273,66274

Oxazepam

OXAZ

66235,66236

PAA (Phenyl Acetic Acid)

PAA

66281,66282

Palmitic acid in amniotic fluid

PALM

66243,66244

Paracetamol

PARA

66235,66236

Paraprotein Investigation by

 

 

- immuno-electrophoresis or immunofixation

PPRO

71001,71002

- on concurrently collected serum or urine

PPSU

71003,71004

Paraquat

PARQ

66235,66236

Parathyroid Hormone

PTH

66301,66302

Partial Thromboplastin Time

PTT

65029,65030

Passovy Factor

PF

65045,65046

Pentabarb

PENT

66235,66236

Pentagastrin

PSTR

66297,66298

Perhexiline

PHEX

66235,66236

pH measurement of body fluids other man urine

PH

66213,66214

Phenobarbitone

PHBA

66235,66236

Phensuximide

PHEN

66235,66236

Phenyl Acetic Acid

PAA

66281,66282

Phenytoin

PHEY

66235,66236


 

Approved item name of test in Schedule

Abbreviation

Item Number

Phosphate

PHOS

66201,66202

Phosphatidylglycerol

PTGL

66243,66244

Plasminogen

PLAS

65037,65038

Platelet Aggregation

PLTG

65041,65042

Count

PLTC

65001,65002

Porphyrins (quantitative test, one or more fractions)

PR

66281,66282

Potassium

K

66201,66202

Prealbumin

PALB

66251,66252

Prednisolone

PRED

66235,66236

Primidone

PRIM

66235,66236

Procainamide

PCAM

66235,66236

Progesterone

PROG

66301,66302

Prolactin

PROL

66301,66302

Prominal

PROM

66235,66236

Propranolol

PPNO

66235,66236

Prostate specific antigen

PSA

66251,66252

Prostatic Acid Phosphatase

ACP

66251,66252

Protein Total

PROT

66201,66202

C

PROC

65037,65038

S

PROS

65037,65038

Quantitative estim. of specific protein

 

 

- Alpha feto protein

AFP

66251,66252

- Alpha-1 antitrypsin

AAT

66251,66252

- Alpha-2 macroglobulin

AMAC

66251,66252

- Beta-2 microglobulin

BMIC

66251,66252

- C-l esterase inhibitor

CEI

66251,66252

- Caeruloplasmin

CPLS

66251,66252

- Ferritin (see also Iron Studies)

FERR

66251,66252

- Haptoglobins

HGLB

66251,66252

- Microalbumin

MALB

66251,66252

- Transferrin (see also Iron Studies)

TRAN

66251,66252

Prothrombin Time

PT

65029,65030

Pyruvate

PVTE

66273,66274

Quinalbarb

QUIB

66235,66236

Quinidine

QUIN

66235,66236

Quinine

QNN

66235,66236

Red Cell Folate and Serum B12 and Serum Folat if required

 

 

RCF

66267,66268

Cell Porphyrins - qualitative test

RCP

65027,65028

Renin

REN

66301,66302

Respiratory Syncytial Virus

RSVN

69219,69220

Reticulocyte Count

RETC

65001,65002


 

Approved item name of test in Schedule

Abbreviation

Item Number

Rheumatoid Factor

RF

71033,71034

Factor Quantitation

RFQ

71035,71036

RSV - Respiratory Syncytial Virus

RSVN

69219,69220

Salicylate-Aspirin

SALI

66235,66236

Secretin

SSGR

66297,66298

Selenium

SE

66277,66278

Semen examination

SEE

73523,73524

examination for spermatozoa

SES

73521,73522

Serotonin

5HT

66273,66274

Serum B12

B12

66265,66266

Folate (with B12)

FOL

66265,66266

Folate (with B12 Red Cell Folate)

RCF

66267,66268

Sex Hormone Binding globulin

SHBG

66301,66302

Snake venom

HISS

66231,66232

Sodium

NA

66201,66202

Somatomedin

SOMA

66301,66302

Sotalol

SALL

66235,66236

Specific IgG or IgE antibodies

ALLG

71015,71016

Sperm antibodies

SAB

73525,73526

penetrating ability

SPA

73525,73526

Stellazine

STEL

66235,66236

Strontium

SR

66277,66278

Sulphadimidine

SPDD

66235,66236

Sulthiame (Ospolot)

SUL

66235,66236

Synacthen Stimulation Test

SYNS

66301,66302

Testosterone

TES

66301,66302

Thalassaemia Studies

TS

65011,65012

Theophylline

THEO

66235,66236

Therapeutic Drugs not listed must be written in full

 

----

Thiopentone

TOPO

66235,66236

Thioridazine

THIO

66235,66236

Thrombin Time

TT

65029,65030

Thyroglobulin

TGL

66251,66252

Thyroid function tests

TFT

66291,66292

stimulating hormone

TSH

66301,66302

stimulating hormone (where not requested as part of TSTs)

TSH

66301,66302

Thyrotrophin Releasing Hormone Test

TRH

66293,66294

Tissue antigens which are not listed must be written in full

 

----

Tocainide

TOCN

66235,66236

Total free fatty acids

TFFA

66273,66274


 

Approved item name of test in Schedule

Abbreviation

Item Number

Transferrin (see also Iron Studies)

TRAN

66251,66252

Triglycerides

TRIG

66201,66202

Trimipramine

TRIM

66235,66236

TSH (where not requested as part of a thyroid function test)

TSH

66301,66302

Tumour Markers

 

 

CA-125 antigen

C125

66251,66252

CA-19.9 antigen

CA19

66251,66252

CA-15.3 antigen

CA15

66251,66252

Carcinoembryonic antigen

CEA

66251,66252

Hormone receptor ovarian

HRO

66315,66316

Mammary serum antigen

MSA

66251,66252

Mucin like carcinoma associated antigen

MCA

66251,66252

Neuron specific enolase

NSEN

66251,66252

Prostate specific antigen

PSA

66251,66252

Prostatic Acid Phosphatase-one or more fractions

ACP

66251,66252

Thyroglobulin

TGL

66251,66252

Urate

URAT

66201,66202

Urea

U

66201,66202

Urine Bilirubin

UBIL

66213,66214

Cysteine (see Urine Cystine)

UCYS

66213,66214

Cystine (Cysteine)

UCYS

66213,66214

Haemoglobin

UHB

66213,66214

Melanin (Melanogen)

UML

66213,66214